國家衛生研究院 NHRI:Items for Author

Year

Loading year class tree, please wait....

Items for Author "Li, CP"

Return to Browse by Author

Showing 61 items.

Collection	Date	Title	Relation
[黃煥常(2000-2008)] 期刊論文	2008-07	Role of vortices in cavitation formation in the flow across a mechanical heart valve	-
[黃煥常(2000-2008)] 會議論文/會議摘要	2008-03	Squeeze flow measurements in mechanical heart valves	-
[黃煥常(2000-2008)] 會議論文/會議摘要	2008-03	Cavitation behavior observed in three monoleaflet mechanical heart valves under accelerated testing conditions	-
[黃智興] 期刊論文	2019-12-17	Endothelial-mesenchymal transition harnesses HSP90alpha-secreting M2-macrophages to exacerbate pancreatic ductal adenocarcinoma	-
[黃智興] 期刊論文	2018-02-01	Myeloid-derived macrophages and secreted HSP90alpha induce pancreatic ductal adenocarcinoma development	-
[黃智興] 期刊論文	2006	Sesamin inhibits vascular endothelial cell growth and angiogenic activity of lung adenocarcinoma cells	-
[黃智興] 期刊論文	2005-12-15	Tumor beta-1,4-galactosyltransferase IV overexpression is closely associated with colorectal cancer metastasis and poor prognosis	-
[黃智興] 期刊論文	2004-01	A G-quadruplex ligand 3,3 '-diethyloxadicarbocyanine iodide induces mitochondrion-mediated apoptosis but not decrease of telomerase activity in nasopharyngeal carcinoma NPC-TW01 cells	-
[陳麗光] 期刊論文	2013-07	Investigating the utilization of radiological services by physician patients: A population-based cohort study in Taiwan	-
[陳立宗] 期刊論文	2024-05	Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer	-
[陳立宗] 期刊論文	2023-02-05	Real-world data validation of NAPOLI-1 nomogram for the prediction of overall survival in metastatic pancreatic cancer	-
[陳立宗] 期刊論文	2022-06-22	Dosing pattern and early cumulative dose of liposomal irinotecan in metastatic pancreatic cancer: A real-world multicenter study	-
[陳立宗] 期刊論文	2022-04	A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study	-
[陳立宗] 期刊論文	2020-02	Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study	-
[陳立宗] 期刊論文	2020-01	Liposomal irinotecan + 5-FU/LV in metastatic pancreatic cancer: Subgroup analyses of patient, tumor, and previous treatment characteristics in the pivotal NAPOLI-1 trial	-
[陳立宗] 期刊論文	2018-11-07	Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial	-
[陳立宗] 期刊論文	2017-08	A randomized phase II study of gemcitabine plus Z-360, a CCK2 receptor-selective antagonist, in patients with metastatic pancreatic cancer as compared with gemcitabine plus placebo	-
[陳立宗] 期刊論文	2016-02	Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): A global, randomised, open-label, phase 3 trial	-
[陳立宗] 期刊論文	2014-07	Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of High-Dose 5-Fluorouracil and Leucovorin as first-line treatment for patients with advanced gastric cancer	-
[陳立宗] 期刊論文	2010-10	A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer	-
[陳立宗] 期刊論文	2008	Fever after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis	-
[陳立宗] 期刊論文	2006-07-17	An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer	-
[陳立宗] 會議論文/會議摘要	2022-02-01	A prospective phase II study of biweekly S-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma	-
[陳立宗] 會議論文/會議摘要	2018-02	Subgroup analysis by baseline (BL) weight-associated parameters: A phase III study of liposomal irinotecan (nal-IRI)+/--5fluorouracil/leucovorin (5-FU/LV) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with g	-
[陳立宗] 會議論文/會議摘要	2017-11	Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: A phase 3 study of nal-IRI65-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy	-
[陳立宗] 會議論文/會議摘要	2017-09	Prognostic value of baseline neutrophil-to-lymphocyte ratio for predicting clinical outcome in metastatic pancreatic ductal adenocarcinoma (mPDAC) patients treated with liposomal irinotecan (nal-IRI)+5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV alon	-
[陳立宗] 會議論文/會議摘要	2017-06-26	Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: A phase 3 study of nal-IRI +/- 5-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy	-
[陳立宗] 會議論文/會議摘要	2017-05	The prognostic value of baseline neutrophilto-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for predicting clinical outcome in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan (nal-IRI; MM	-
[陳立宗] 會議論文/會議摘要	2017-02	Characteristics of long-term survivors in a randomized phase III trial (NAPOLI-1) of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan (nal-IRI; MM-398)+5-FU/LV	-
[陳立宗] 會議論文/會議摘要	2016-12	Efficacy and safety of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02, BAX-2398) in patients with metastatic pancreatic cancer in Asia: A subgroup analysis of the phase 3 NAPOLI-1 Study	-
[陳立宗] 會議論文/會議摘要	2016-10	Final results of NAPOLI-1: A phase 3 study of nal-IRI (MM-398) +/- 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy	-
[陳立宗] 會議論文/會議摘要	2016-10	Time course of selected treatment emergent adverse events (TEAEs) in NAPOLI-1: A phase 3 study of nal-IRI (MM-398) +/- 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based ther	-
[陳立宗] 會議論文/會議摘要	2016-05	Updated overall survival (OS) analysis of NAPOLI-1: Phase 3 study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine	-
[陳立宗] 會議論文/會議摘要	2016-02	Expanded analyses of NAPOLI-1: Phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy	-
[陳立宗] 會議論文/會議摘要	2016-02	Phase III study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy	-
[陳立宗] 會議論文/會議摘要	2015-01	Expanded analyses of napoli-1: Phase 3 study of MM-398 (nal-IRI), with or without 5-fluorouracil and leucovorin, versus 5-fluorouracil and leucovorin, in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy	-
[陳立宗] 會議論文/會議摘要	2011-09	Phase II study of low-dose everolimus plus weekly cisplatin and 24-hour infusion of high-dose 5-fluorouracil and leucovorin for first-line treatment of metastatic or recurrent gastric cancers	-
[陳立宗] 會議論文/會議摘要	2005-06	An open, multi-center, phase II clinical trial to evaluate efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer preliminary report	-
[鄒粹軍] 期刊論文	2014-05-06	Combination of a fast cleanup procedure and a DR-CALUX® bioassay for dioxin surveillance in Taiwanese soils	-
[邱燕楓] 期刊論文	2023-09	Carbohydrate antigen 19-9 response to initial adjuvant chemotherapy predicts survival and failure pattern of resected pancreatic adenocarcinoma but not which patients are suited for additional adjuvant chemoradiation therapy: From a prospective randomized study	-
[蘇勇曄] 期刊論文	2024-06	Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation	-
[蘇勇曄] 期刊論文	2022-11-15	The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinoma	-
[蘇勇曄] 期刊論文	2021-11-20	Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study	-
[蕭金福] 期刊論文	2018-07	The clinical impact of the novel tumor marker DR-70 in unresectable gastric cancer patients	-
[蕭金福] 期刊論文	2016-01	A phase II study of sequential capecitabine plus oxaliplatin followed by docetaxel plus capecitabine in patients with unresectable gastric adenocarcinoma: The TCOG 3211 clinical trial	-
[蕭金福] 會議論文/會議摘要	2015-12	A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma-TCOG 3211 clinical trial	-
[蕭金福] 會議論文/會議摘要	2015-05	A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial	-
[彭汪嘉康(1996-2007)] 期刊論文	2008-06	Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma	-
[彭汪嘉康(1996-2007)] 期刊論文	2003-12	Spider angiomas in patients with liver cirrhosis: Role of vascular endothelial growth factor and basic fibroblast growth factor	-
[常慧如] 會議論文/會議摘要	2018-10	Randomized, phase III trial comparing adjuvant gemcitabine (Gem) versus Gem plus chemoradiation (CCRT) in curatively resected pancreatic ductal adenocarcinoma (PDAC): A Taiwan cooperative oncology group study	-
[姜乃榕] 期刊論文	2022-09-15	Predictive value of albumin combined with neutrophil-to-lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorin	-
[姜乃榕] 期刊論文	2022-09	A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study	-
[姜乃榕] 期刊論文	2022-06	Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin	-
[姜乃榕] 期刊論文	2022-04-15	The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan	-
[姜乃榕] 會議論文/會議摘要	2023-06	Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors	-
[姜乃榕] 會議論文/會議摘要	2021-05	TCOG T5217 trial: A phase II randomized study of SLOG versus modified FOLFIRINOX as the first-line treatment in locally advanced or metastatic pancreatic ductal adenocarcinoma	-
[劉士任] 期刊論文	2005-03	Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma	-
[其他] 期刊論文	2011-05	Turbulence characteristics downstream of a new trileaflet mechanical heart valve	-
[其他] 期刊論文	2010-10	Cavitation phenomena in mechanical heart valves: Studied by using a physical impinging rod system	-
[其他] 期刊論文	2010-03	Estimation of viscous dissipative stresses induced by a mechanical heart valve using PIV data	-
[其他] 期刊論文	2012-03	Role of vortices in cavitation formation in the flow at the closure of a bileaflet mitral mechanical heart valve	-

Loading...

Category

Year

Items for Author "Li, CP"